Last updated: July 10, 2026

Application No. 19/421,039

Untitled Application

Unknown

Filed

Priority

Dec 07, 2020 — provisional 63/122,469 +2 more

Examiner

CHONG, YONG SOO

Art Unit

Tech Center

TONIX PHARMA LIMITED

Assignee

Tonix Pharma Limited

OA Round

1 (Non-Final)

This examiner grants 44% of cases after interview

— +41.4% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 878 resolved cases, 2023–2026

Examiner Intelligence

CHONG, YONG SOO View full profile →

Grants 44% of resolved cases

Career Allowance Rate

383 granted / 878 resolved

-16.4% vs TC avg

Strong +41% interview lift

Without

With

+41.4%

Interview Lift

resolved cases with interview

Typical timeline

3y 11m

Avg Prosecution

60 currently pending

Career history

944

Total Applications

across all art units

Statute-Specific Performance

§101

0.6%

-39.4% vs TC avg

§103

71.4%

+31.4% vs TC avg

§102

17.2%

-22.8% vs TC avg

§112

5.0%

-35.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 878 resolved cases

Prosecution Timeline

Apr 15, 2026

Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/034,578

Patent 12673062

COMBINATION THERAPY OF TETRACYCLIC QUINOLONE ANALOGS FOR TREATING CANCER

5y 9m to grant Granted Jul 07, 2026

17/778,124

Patent 12673034

PEPTIDES, COMPOUNDS, COMPOSITIONS AND METHODS FOR INHIBITING SOX9

4y 1m to grant Granted Jul 07, 2026

17/625,429

Patent 12667566

COMBINATION THERAPY OF GPR119 AGONISTS AND DPP-4 INHIBITORS

4y 5m to grant Granted Jun 30, 2026

18/281,600

Patent 12668604

Heteroaryl compounds as inhibitors of RIP2 kinase, composition and application thereof

2y 9m to grant Granted Jun 30, 2026

18/010,249

Patent 12655089

HYDROXYNORKETAMINE ANALOGUES, COMPOSITIONS COMPRISING SAME AND METHODS OF USE THEREOF

3y 6m to grant Granted Jun 16, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

44%

Grant Probability

85%

With Interview (+41.4%)

3y 11m

Median Time to Grant

Low

PTA Risk

Based on 878 resolved cases by this examiner. Grant probability derived from career allowance rate.